Home | News | Events | Contact Us | English | 繁體中文 | 日本語
About Us Product & Service Facilities Quality & Compliance For Investors Career
Quality & Compliance 
Home / Quality & Compliance / Intellectual Property
Intellectual Property 
Formosa Laboratories, Inc. respects the intellectual property of others, and we ask our users and customers to do the same.

 Baricitinib

Patent number Country
US10766900B2 US

Calcipotriol

Patent number Country
Nr. 10 2006 047 173 DE
ZL 200510076365.3 CN
ZL 2005 1 0113460.6 CN
 

 Fondaparinux

Patent number Country
I628187 TW
 

 Maxacalcitol

Patent number Country
特許第5563324號 JP
特許第5652723號 JP
I461396 TW
 

Montelukast Na

Patent number Country
US 7,271,268 B1 US
US 7,700,776 B2 US
US 8,399,675 B2 US
Nr. 10 2007 061 630 DE
ZL 2010 1 0149168.0 CN
ZL 2010 1 0201170.8 CN
ZL 200810083198.9 CN
 

 Nilotinib

Patent number Country
US 9,187,452 US
 

Paricalcitol

Patent number Country
US 7,491,712 US
US 8,026,379 US
US 7,645,911 US
Nr. 10 2008 061 497 DE
I367205 TW
Nr. 10 2009 013 609 DE
 

 Pazopanib Hydrochloride

Patent number Country
US10626110B2 US
 

 Ribociclib

Patent number Country
I718533 TW
 

 Rucaparib Camsylate

Patent number Country
US11,021,483 US
 

 Sugammadex Sodium

Patent number Country
US10233263B1 US
US10336835B2 US
I703163 TW
 


 



 
 
Copyright ©2014 Formosa Laboratories, Inc. All Rights Reserved.
丙肝